CRIP1涉及多发性骨髓瘤的发病因子,通过蛋白质酶和自的双重调节
Peixia Tang1, Zhen Yu1, Hao Sun2
1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China; Tianjin Institutes of Health Science, Tianjin, China.
EBioMedicine
|January 10, 2024
概括
高CRIP1表达表明多发性骨髓瘤 (MM) 的结果不佳. 这项研究揭示了CRIP1通过调节蛋白酶体和自途径对蛋白酶体抑制剂耐药性的作用,为MM提供了新的治疗见解.
科学领域:
- 血液学的恶性瘤
- 癌症生物学 癌症生物学
- 疾病的分子机制.
背景情况:
- 多发性骨髓瘤 (MM) 是一种无法治愈的血细胞恶性瘤,其中蛋白质平衡对于生存至关重要.
- 蛋白质酶抑制剂 (PI) 是有效的治疗方法,但自可以降低敏感性.
- 了解耐药机制对于改善MM患者的治疗结果至关重要.
研究的目的:
- 研究CRIP1在多发性骨髓瘤发病过程中的作用及其对蛋白酶体抑制剂 (PI) 耐药性的影响.
- 阐明CRIP1影响MM细胞中的蛋白质稳态,蛋白酶体活性和自的分子机制.
主要方法:
- 在健康捐赠者和MM患者 (NDMM,RRMM) 中对CRIP1的基因表达分析.
- 在MM细胞系中操纵CRIP1 (shRNA,过度表达) 以评估增殖,入侵,迁移,蛋白酶体活动和自.
- 共同免疫沉 (Co-IP) 和并联亲和性净化/质谱 (TAP/MS) 以确定CRIP1结合伙伴.
- 在活体老鼠异种移植模型中,评估CRIP1在MM增殖和耐药性中的作用.
主要成果:
- 增加的CRIP1表达与不良的临床结果相关,并作为复发性/耐药性MM (RRMM) 的生物标志物.
- 克里普1通过调节MM细胞中的蛋白质酶和自活动来关键调节蛋白质稳态.
- 通过与USP7和PA200结合,CRIP1促进PI耐药性,通过PA200稳定增强蛋白酶体活性和自酶体成熟.
结论:
- CRIP1/USP7/PA200复合体在MM病变发生过程中发挥着关键作用,它通过影响依赖于全方位素的蛋白酶体降解和自作用.
- 克里普1是MM细胞生存和耐药性的关键调节者,突出其作为治疗点的潜力.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
The Proteasome
8.7K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.7K
Regulated Protein Degradation
7.3K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.3K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Delivery Pathways to the Lysosome
6.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.6K


